House of Lords Business
Show full summary

Lord Mendelsohn to ask His Majesty's Government, further to the Written Answer by Lord Markham on 1 February (HL4939), when the figures referred to in the Written Answer on 12 April 2022 (HL7711), which provide the number of clinically extremely vulnerable individuals who do not make antibodies through the vaccinations currently available but who would be protected by pre-exposure prophylaxis from monoclonal antibodies, will be updated.  HL5699

Question HL5699: tabled on 20 February 2023 and due for answer by 6 March 2023

This type of business sits within the Questions & Statements category.

This question has been answered by the relevant Government Department.

Question text

Lord Mendelsohn to ask His Majesty's Government, further to the Written Answer by Lord Markham on 1 February (HL4939), when the figures referred to in the Written Answer on 12 April 2022 (HL7711), which provide the number of clinically extremely vulnerable individuals who do not make antibodies through the vaccinations currently available but who would be protected by pre-exposure prophylaxis from monoclonal antibodies, will be updated.  HL5699
Legend for business item text
† Item that is new or altered.
* Item is an oral question.
Numbers starting HL are unique identifiers for written questions, Bills or papers.

Member's Registered Interests

There are no interests to show.

Main Member

Lord Mendelsohn
Labour
Life peer